Transcriptional Control of SLC26A4 is Involved in Pendred Syndrome and Nonsyndromic Enlargement of Vestibular Aqueduct (DFNB4)

Overview

Journal Am J Hum Genet

Publisher Cell Press

Specialty Genetics

Date 2007 May 16

PMID 17503324

Citations 90

Authors

Tao Yang

Hilmar Vidarsson

Sandra Rodrigo-Blomqvist

Sally S Rosengren

Sven Enerback

Richard J H Smith

Affiliations

Soon will be listed here.

Abstract

Although recessive mutations in the anion transporter gene SLC26A4 are known to be responsible for Pendred syndrome (PS) and nonsyndromic hearing loss associated with enlarged vestibular aqueduct (EVA), also known as "DFNB4," a large percentage of patients with this phenotype lack mutations in the SLC26A4 coding region in one or both alleles. We have identified and characterized a key transcriptional regulatory element in the SLC26A4 promoter that binds FOXI1, a transcriptional activator of SLC26A4. In nine patients with PS or nonsyndromic EVA, a novel c.-103T-->C mutation in this regulatory element interferes with FOXI1 binding and completely abolishes FOXI1-mediated transcriptional activation. We have also identified six patients with mutations in FOXI1 that compromise its ability to activate SLC26A4 transcription. In one family, the EVA phenotype segregates in a double-heterozygous mode in the affected individual who carries single mutations in both SLC26A4 and FOXI1. This finding is consistent with our observation that EVA occurs in the Slc26a4(+/-); Foxi1(+/-) double-heterozygous mouse mutant. These results support a novel dosage-dependent model for the molecular pathogenesis of PS and nonsyndromic EVA that involves SLC26A4 and its transcriptional regulatory machinery.

Citing Articles

Recent Developments in the Treatment of Pediatric Distal Renal Tubular Acidosis.

Boyer O, Ould Rabah M, Preka E Paediatr Drugs. 2024; 26(6):649-657.

PMID: 39325135 DOI: 10.1007/s40272-024-00651-9.

Unraveling the Genetic Basis of Combined Deafness and Male Infertility Phenotypes through High-Throughput Sequencing in a Unique Cohort from South India.

Margret J, Jayasankaran C, Amritkumar P, Azaiez H, Srisailapathy C Adv Genet (Hoboken). 2024; 5(2):2300206.

PMID: 38884051 PMC: 11170077. DOI: 10.1002/ggn2.202300206.

Mechanism of anion exchange and small-molecule inhibition of pendrin.

Wang L, Hoang A, Gil-Iturbe E, Laganowsky A, Quick M, Zhou M Nat Commun. 2024; 15(1):346.

PMID: 38184688 PMC: 10771415. DOI: 10.1038/s41467-023-44612-1.

Homozygous Missense Variants in FOXI1 and TMPRSS3 Genes Associated with Non-syndromic Deafness in Moroccan Families.

AitRaise I, Amalou G, Bakhchane A, Bousfiha A, Abdelghaffar H, Majida C Biochem Genet. 2023; 62(3):1914-1924.

PMID: 37777971 DOI: 10.1007/s10528-023-10515-5.

Cancer Predisposition Syndromes and Thyroid Cancer: Keys for a Short Two-Way Street.

Balinisteanu I, Panzaru M, Caba L, Ungureanu M, Florea A, Grigore A Biomedicines. 2023; 11(8).

PMID: 37626640 PMC: 10452453. DOI: 10.3390/biomedicines11082143.

References

Royaux I, Suzuki K, Mori A, Katoh R, Everett L, Kohn L . Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells. Endocrinology. 2000; 141(2):839-45. DOI: 10.1210/endo.141.2.7303. View

Stroud J, Wu Y, Bates D, Han A, Nowick K, Paabo S . Structure of the forkhead domain of FOXP2 bound to DNA. Structure. 2006; 14(1):159-66. DOI: 10.1016/j.str.2005.10.005. View

Bidart J, Mian C, Lazar V, Russo D, Filetti S, Caillou B . Expression of pendrin and the Pendred syndrome (PDS) gene in human thyroid tissues. J Clin Endocrinol Metab. 2000; 85(5):2028-33. DOI: 10.1210/jcem.85.5.6519. View

Campbell C, Cucci R, Prasad S, Green G, Edeal J, Galer C . Pendred syndrome, DFNB4, and PDS/SLC26A4 identification of eight novel mutations and possible genotype-phenotype correlations. Hum Mutat. 2001; 17(5):403-11. DOI: 10.1002/humu.1116. View

Lerer I, Sagi M, Ben-Neriah Z, Wang T, Levi H, Abeliovich D . A deletion mutation in GJB6 cooperating with a GJB2 mutation in trans in non-syndromic deafness: A novel founder mutation in Ashkenazi Jews. Hum Mutat. 2001; 18(5):460. DOI: 10.1002/humu.1222. View

Wilch E, Zhu M, Burkhart K, Regier M, Elfenbein J, Fisher R . Expression of GJB2 and GJB6 is reduced in a novel DFNB1 allele. Am J Hum Genet. 2006; 79(1):174-9. PMC: 1474119. DOI: 10.1086/505333. View

Rodrigo Blomqvist S, Vidarsson H, Soder O, Enerback S . Epididymal expression of the forkhead transcription factor Foxi1 is required for male fertility. EMBO J. 2006; 25(17):4131-41. PMC: 1560351. DOI: 10.1038/sj.emboj.7601272. View

Pallares-Ruiz N, Blanchet P, Mondain M, Claustres M, Roux A . A large deletion including most of GJB6 in recessive non syndromic deafness: a digenic effect?. Eur J Hum Genet. 2002; 10(1):72-6. DOI: 10.1038/sj.ejhg.5200762. View

Hulander M, Kiernan A, Rodrigo Blomqvist S, Carlsson P, Samuelsson E, Johansson B . Lack of pendrin expression leads to deafness and expansion of the endolymphatic compartment in inner ears of Foxi1 null mutant mice. Development. 2003; 130(9):2013-25. DOI: 10.1242/dev.00376. View

10.

Tsukamoto K, Suzuki H, Harada D, Namba A, Abe S, Usami S . Distribution and frequencies of PDS (SLC26A4) mutations in Pendred syndrome and nonsyndromic hearing loss associated with enlarged vestibular aqueduct: a unique spectrum of mutations in Japanese. Eur J Hum Genet. 2003; 11(12):916-22. DOI: 10.1038/sj.ejhg.5201073. View

11.

Prasad S, Kolln K, Cucci R, Trembath R, Van Camp G, Smith R . Pendred syndrome and DFNB4-mutation screening of SLC26A4 by denaturing high-performance liquid chromatography and the identification of eleven novel mutations. Am J Med Genet A. 2003; 124A(1):1-9. DOI: 10.1002/ajmg.a.20272. View

12.

Rodrigo Blomqvist S, Vidarsson H, Fitzgerald S, Johansson B, Ollerstam A, Brown R . Distal renal tubular acidosis in mice that lack the forkhead transcription factor Foxi1. J Clin Invest. 2004; 113(11):1560-70. PMC: 419486. DOI: 10.1172/JCI20665. View

13.

Blons H, Feldmann D, Duval V, Messaz O, Denoyelle F, Loundon N . Screening of SLC26A4 (PDS) gene in Pendred's syndrome: a large spectrum of mutations in France and phenotypic heterogeneity. Clin Genet. 2004; 66(4):333-40. DOI: 10.1111/j.1399-0004.2004.00296.x. View

14.

Grimberg J, Nawoschik S, Belluscio L, McKee R, Turck A, Eisenberg A . A simple and efficient non-organic procedure for the isolation of genomic DNA from blood. Nucleic Acids Res. 1989; 17(20):8390. PMC: 334995. DOI: 10.1093/nar/17.20.8390. View

15.

Overdier D, Porcella A, Costa R . The DNA-binding specificity of the hepatocyte nuclear factor 3/forkhead domain is influenced by amino-acid residues adjacent to the recognition helix. Mol Cell Biol. 1994; 14(4):2755-66. PMC: 358641. DOI: 10.1128/mcb.14.4.2755-2766.1994. View

16.

Pierrou S, Hellqvist M, Samuelsson L, Enerback S, Carlsson P . Cloning and characterization of seven human forkhead proteins: binding site specificity and DNA bending. EMBO J. 1994; 13(20):5002-12. PMC: 395442. DOI: 10.1002/j.1460-2075.1994.tb06827.x. View

17.

de Kok Y, Merkx G, van der Maarel S, Huber I, Malcolm S, Ropers H . A duplication/paracentric inversion associated with familial X-linked deafness (DFN3) suggests the presence of a regulatory element more than 400 kb upstream of the POU3F4 gene. Hum Mol Genet. 1995; 4(11):2145-50. DOI: 10.1093/hmg/4.11.2145. View

18.

Everett L, Glaser B, Beck J, Idol J, Buchs A, Heyman M . Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet. 1997; 17(4):411-22. DOI: 10.1038/ng1297-411. View

19.

Li X, Everett L, Lalwani A, Desmukh D, Friedman T, Green E . A mutation in PDS causes non-syndromic recessive deafness. Nat Genet. 1998; 18(3):215-7. DOI: 10.1038/ng0398-215. View

20.

Hulander M, Wurst W, Carlsson P, Enerback S . The winged helix transcription factor Fkh10 is required for normal development of the inner ear. Nat Genet. 1998; 20(4):374-6. DOI: 10.1038/3850. View